Initiating sacubitril/valsartan (LCZ696) in heart failure: results of TITRATION, a double-blind, randomized comparison of two uptitration regimens


Creative Commons License

Senni M., McMurray J. J. V. , Wachter R., McIntyre H. F. , Reyes A., Majercak I., ...Daha Fazla

EUROPEAN JOURNAL OF HEART FAILURE, cilt.18, ss.1193-1202, 2016 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 18 Konu: 9
  • Basım Tarihi: 2016
  • Doi Numarası: 10.1002/ejhf.548
  • Dergi Adı: EUROPEAN JOURNAL OF HEART FAILURE
  • Sayfa Sayıları: ss.1193-1202

Özet

AimsTo assess the tolerability of initiating/uptitrating sacubitril/valsartan (LCZ696) from 50 to 200 mg twice daily (target dose) over 3 and 6 weeks in heart failure (HF) patients (ejection fraction 35%).